FDA Advisory No. 2019-500 || Updated contact information for DOH surveillance injuries and illness arising from the use of electronic nicotine and non-nicotine delivery systems (ENDS/ENNDS)

The Food and Drug Administration (FDA) informs heads of hospitals that all DOH-retained hospitals shall report all probable and confirmed cases of Electronic Cigarette or Vaping Product-Associated Lung Injury (EVALI) to [email protected].

To capture all the necessary epidemiologic and clinical data, please complete the EVALI case report form enclosed in this advisory.

Private hospitals and public hospitals not retained by the DOH are likewise strongly encouraged to use the same reporting tools to standardize case reporting communication processes.

Dissemination of this advisory to all concerned is hereby requested.

Attachment:-> FDA Advisory No.2019-500